The University of Chicago Header Logo

Connection

Abhinav Sidana to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications Abhinav Sidana has written about Prostatic Neoplasms.
Abhinav Sidana
Connection Strength
7.502
Prostatic Neoplasms
  1. Prostate ablation for the management of localized prostate cancer. Urol Oncol. 2025 Mar; 43(3):194.e9-194.e17.
    View in: PubMed
    Score: 0.425
  2. Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer. Urol Oncol. 2024 05; 42(5):158.e1-158.e10.
    View in: PubMed
    Score: 0.400
  3. Real-Time and Delayed Imaging of Tissue and Effects of Prostate Tissue Ablation. Curr Urol Rep. 2023 Oct; 24(10):477-489.
    View in: PubMed
    Score: 0.386
  4. Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients? Aging Male. 2022 Dec; 25(1):23-28.
    View in: PubMed
    Score: 0.370
  5. How does a prebiopsy mri approach for prostate cancer diagnosis affect prostatectomy upgrade rates? Urol Oncol. 2021 11; 39(11):784.e11-784.e16.
    View in: PubMed
    Score: 0.331
  6. Is a targeted biopsy-only approach for prostate cancer diagnosis ready for the prime time? Nat Rev Urol. 2021 02; 18(2):75-76.
    View in: PubMed
    Score: 0.326
  7. Multiparametric MRI-ultrasound fusion prostate biopsy in patients without prior diagnosis of prostate cancer: beyond centers of excellence. Aging Male. 2020 Dec; 23(5):1570-1575.
    View in: PubMed
    Score: 0.325
  8. A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies. J Endourol. 2020 10; 34(10):1095-1098.
    View in: PubMed
    Score: 0.318
  9. Equal access to health care reduces racial disparities in prostate cancer outcomes. Cancer. 2020 09 15; 126(18):4256-4257.
    View in: PubMed
    Score: 0.314
  10. Multidisciplinary clinics: A possible means to help to eliminate racial disparities in prostate cancer. Cancer. 2020 06 15; 126(12):2938-2939.
    View in: PubMed
    Score: 0.306
  11. Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer. Prostate Cancer Prostatic Dis. 2020 12; 23(4):567-572.
    View in: PubMed
    Score: 0.306
  12. Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies. Int Urol Nephrol. 2019 Jul; 51(7):1101-1106.
    View in: PubMed
    Score: 0.288
  13. Partial gland therapy for prostate cancer. Cancer. 2019 03 01; 125(5):818-819.
    View in: PubMed
    Score: 0.282
  14. Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol. 2018 Jul; 53(3):227-233.
    View in: PubMed
    Score: 0.271
  15. Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI. AJR Am J Roentgenol. 2018 06; 210(6):W268.
    View in: PubMed
    Score: 0.271
  16. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
    View in: PubMed
    Score: 0.270
  17. Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol. 2018 Jul; 53(3):200-205.
    View in: PubMed
    Score: 0.269
  18. Mechanism of growth inhibition of prostate cancer xenografts by valproic acid. J Biomed Biotechnol. 2012; 2012:180363.
    View in: PubMed
    Score: 0.183
  19. Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012 Jan; 72(1):58-64.
    View in: PubMed
    Score: 0.166
  20. Does valproic acid induce neuroendocrine differentiation in prostate cancer? J Biomed Biotechnol. 2011; 2011:607480.
    View in: PubMed
    Score: 0.160
  21. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022 Mar-Apr; 48(2):263-274.
    View in: PubMed
    Score: 0.088
  22. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. Diagn Interv Radiol. 2021 May; 27(3):394-400.
    View in: PubMed
    Score: 0.083
  23. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urol Oncol. 2021 11; 39(11):781.e17-781.e24.
    View in: PubMed
    Score: 0.082
  24. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. Minerva Urol Nephrol. 2022 10; 74(5):581-589.
    View in: PubMed
    Score: 0.081
  25. Imaging for prostate cancer: reimbursements. Abdom Radiol (NY). 2020 12; 45(12):4114-4116.
    View in: PubMed
    Score: 0.081
  26. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World J Urol. 2021 Mar; 39(3):677-686.
    View in: PubMed
    Score: 0.079
  27. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. Eur Urol. 2020 09; 78(3):371-378.
    View in: PubMed
    Score: 0.078
  28. Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy. Int Urol Nephrol. 2020 Apr; 52(4):633-638.
    View in: PubMed
    Score: 0.075
  29. Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy. Int Urol Nephrol. 2019 Aug; 51(8):1349-1355.
    View in: PubMed
    Score: 0.072
  30. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer. Urol Oncol. 2019 03; 37(3):182.e1-182.e8.
    View in: PubMed
    Score: 0.070
  31. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer. J Magn Reson Imaging. 2018 11; 48(5):1326-1335.
    View in: PubMed
    Score: 0.067
  32. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? J Urol. 2018 04; 199(4):976-982.
    View in: PubMed
    Score: 0.066
  33. Ruling out clinically significant prostate cancer with negative multi-parametric MRI. Int Urol Nephrol. 2018 Jan; 50(1):7-12.
    View in: PubMed
    Score: 0.065
  34. The Sunshine Act and oncology: Lessons learned from urology. Semin Oncol. 2017 08; 44(4):265-266.
    View in: PubMed
    Score: 0.065
  35. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer. Balkan Med J. 2017 09 29; 34(5):388-396.
    View in: PubMed
    Score: 0.065
  36. MRI-targeted biopsy: is systematic biopsy obsolete? Can J Urol. 2017 Aug; 24(4):8876-8882.
    View in: PubMed
    Score: 0.064
  37. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. Urol Oncol. 2017 01; 35(1):32.e1-32.e7.
    View in: PubMed
    Score: 0.060
  38. Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy. J Urol. 2017 02; 197(2):327-334.
    View in: PubMed
    Score: 0.060
  39. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis. Urol Oncol. 2017 01; 35(1):30.e1-30.e8.
    View in: PubMed
    Score: 0.060
  40. Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Int Urol Nephrol. 2016 Sep; 48(9):1445-52.
    View in: PubMed
    Score: 0.059
  41. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. Urol Oncol. 2016 06; 34(6):254.e15-21.
    View in: PubMed
    Score: 0.058
  42. Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling. J Urol. 2016 07; 196(1):62-7.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.